Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 | BDSX Stock NewsStockTitan·Jul 21 at 09:00 PMBDSX-3.76%
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·Jul 19 at 05:14 AMBDSX-3.76%STT-1.18%
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & Morerttnews·Jun 29 at 03:19 AMMIRM-2.20%TWST+0.90%
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga_article·Jun 15 at 08:15 AMLCLN-0.99%BDSX-3.76%
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy | BDSX Stock NewsStockTitan·May 11 at 12:20 AMBDSX-3.76%IBB+0.91%
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock PriceMarket Beat·May 5 at 02:02 PMBDSX-3.76%FBT+1.71%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·May 5 at 12:05 PMEMBC+4.80%FTRE+8.23%
Biodesix | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 25.56 MEarnings Watch·May 4 at 09:58 PMBDSX-3.76%
Biodesix Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·May 4 at 04:23 PMBDSX-3.76%PBE+1.37%
Biodesix shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 sales guidance with its midpoint above estimates.benzinga_article·May 4 at 03:58 PMBDSX-3.76%LABU-2.54%
Biodesix | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 25.56 MEarnings Watch·May 4 at 03:09 PMBDSX-3.76%
